Bionor Holding AS is a privately held company with shareholders having interest in biotech and vaccine-driven value creation.
As of 31st of December 2017, the company has 20 shareholders and the total number of shares is 38,546,752 with the face value of NOK 0.001 per share. The shares have all equal voting rights. The shares are registered at VPS.
For more information: Contact the CFO Dag Arne Wivelstad by filling the below form.